GOLDMAN SACHS GROUP INC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 11 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$167,000
+3.1%
200,0000.0%0.00%
Q4 2021$162,000
+116.0%
200,000
+100.0%
0.00%
Q3 2021$75,000
-25.0%
100,0000.0%0.00%
Q2 2021$100,000100,0000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 20,000,000$25,176,0001.70%
DeepCurrents Investment Group LLC 22,530,000$28,226,0000.74%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 20,000,000$24,888,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 35,000,000$43,527,0000.26%
AQR Arbitrage LLC 4,100,000$5,164,0000.18%
CSS LLC/IL 3,000,000$3,781,0000.14%
Verition Fund Management LLC 6,579,000$8,286,0000.07%
LAZARD ASSET MANAGEMENT LLC 16,500,000$20,780,0000.03%
Citadel Advisors 43,300,000$54,252,0000.01%
CREDIT SUISSE AG/ 5,017,000$6,243,0000.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders